Candidosis in Heroin Addicts and AIDS: New Immunologic Data on Chronic Mucocutaneous Candidosis

  • E. Drouhet
  • B. Dupont
Part of the Federation of European Microbiological Societies Symposium Series book series (FEMS, volume 50)


Recent reports illustrate that the problem of opportunistic fungal infections is ever-increasing. Invasive fungal infections have been reported in more than 25% of patients who are chronically and intensively immunosuppressed by reason of underlying diseases and modern drug therapy. However, since 1980 the incidence and severity of opportunistic mycoses, particularly Candida infections has been even higher because of new pathological conditions produced by AIDS1–4 and heroin addiction5–7.


Candida Albicans Lemon Juice Heroin Addict Systemic Candidiasis Oral Thrush 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E.Drouhet, B.Dupont, Mycotic infections complicating heroin adaddicts, AIDS and other immunocompromised host conditions, Ann. Ist. Super. Sanita, 23: 735 (1987).Google Scholar
  2. 2.
    R.S.Klein, C.A.Harris, C.B.Small et al., Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome, New Engl. J. Med., 311: 354 (1984).Google Scholar
  3. 3.
    C.Pedersen, J.Gerstoft, B.O.Lindhardt, J.Sindrup, Candida esophagitis associated with acute human immunodeficiency virus infection, J. Infect. Dis., 156: 529 (1987).CrossRefGoogle Scholar
  4. 4.
    A.Tavitian, J.P.Raufman, L.E.Rosenthal, Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodefeciency syndrome, Ann. Intern. Med., 104: 54 (1986).Google Scholar
  5. 5.
    E.Drouhet, B.Dupont, C.Lapresle, P.Ravisse, Nouvelle pathologie: candidose folliculaire et nodulaire avec des localisations ostéoarticulaires et oculaires au cours des septicémies à Candida albicans chez les héroinomanes. Mono et polythérapie antifongique, Bull. Soc. Fr. Mycol. Med., 10: 179 (1981).Google Scholar
  6. 6.
    E.Drouhet, B.Dupont, Laboratory and clinical assessment of ketoconazole in deep-seated mycoses, Am. J. Med., 74 (suppl. 1B): 30 (1983).CrossRefGoogle Scholar
  7. 7.
    B.Dupont and E. Drouhet, Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients, J. Infect. Dis., 152: 577 (1985).PubMedCrossRefGoogle Scholar
  8. 8.
    F.C.Odds, “Candida and Candidosis. A Review and Bibliography, Second edition, Baillière Tindall Publ., London (1988).Google Scholar
  9. 9.
    Y.Cruces Prado and C. de la Torre Fraga, Folliculitis in a couple of heroin addicts, Revista Iberica di Micologia, 3 (Suppl. 1): 579 (1986).Google Scholar
  10. 10.
    J. de la Cuadra Oyanguren, A. Aliaga Boniche, J.L. Sanchez Carazo, Skin disorders in systemic candidiasis of parenteral drug addicts, Revista Iberica de Micologia, 3 (Suppl. 1): S67 (1986).Google Scholar
  11. 11.
    J.M.Mascaro, C.Herrero, I.Bielsa, M.Cedra, Candidiasis en drogadictos por via parenteral, Revista Iberica de Micologia, 3 (Suppl. 1): 575 (1986).Google Scholar
  12. 12.
    R.Perez Vidal, L.Forcé, A.Verdaguer, J.M.Torres Rodriquez, Giménez Camarasa, Candidiasis sistemica en heroinomanos. Resentacion de 13 cases, Revista Iberica de Micologia, 3 (Suppl. 1): S85 (1986).Google Scholar
  13. 13.
    D.Podzamczer and F.Gudiol, Systemic candidiasis in heroin abusers, J. Tnfect. Dis., 153: 1182 (1986).CrossRefGoogle Scholar
  14. 14.
    L.Zubiri, C.Cocojuela, J.Pinol, F.J.Carapeto, Candidiasis diseminada en heroinomanos. Estudio de ocho casos, Acta Dermo-sif., 78: 345 (1987).Google Scholar
  15. 15.
    F.Vanaclocha Sebastiaan, R.Gil Martin, R.Diaz Diaz, P.Jaen Olasolo, L.Iglesias Diez, Systemic candidiasis in heroin addicts: Clinical and pathological study of 22 patients, Revista Iberica de Micologia, 3 (Suppl. 1): S57 (1986).Google Scholar
  16. 16.
    A.Lopoz, N.Vescia, A.De Carolis, G.Gualdi, Le candidosis sistemiche dell heroinomane possono essere imputabili ad in quinaments delle miscelle stupefaceili? Nuovi Annali di Igiene a Microbiol., 34: 109 (1983).Google Scholar
  17. 17.
    M.Etienne, A.Nemery, J.M.Darcis, G.E.Pierard, J.Demonty, Disseminated candidiasis in heroin addicts, Acta Clinica Belgica, 41: 18 (1986).PubMedGoogle Scholar
  18. 18.
    R.J.Hay, Systemic candidiasis in heroin addicts, Br. Med. J., 292: 1096 (1986).CrossRefGoogle Scholar
  19. 19.
    I.F.Rowe, E.D.Wright, C.S.Higgens, J.P.Burnie, Intervertebral infection due to Candida albicans in an intravenous heroin abuser, Ann. Rheum. Dis., 47S6: 522 (1988).Google Scholar
  20. 20.
    G.S.Shankland and M.D.Richardson, Possible role of preserved lemon juice in the epidemiology of Candida endophtalmitis in heroin addicts, Eur. J. Clin. Microbiol. Infect. Dis., 8: 87 (1989).Google Scholar
  21. 21.
    P.J.Collignon and T.C.Sorrell, Candidiasis in heroin abusers, J.Infect. Dis., 155: 595 (1987).PubMedCrossRefGoogle Scholar
  22. 22.
    R.J.McDonough, J.J.Madden, A.Falek, D.A.Shafer, M.Pline, D.Gordon, P.Bokos, J.C.Kuehnie, J.Mendelson, Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes, J.Immunol., 125: 2539 (1980).PubMedGoogle Scholar
  23. 23.
    B.Dupont and E.Drouhet, Fluconazole in the management of oro-pharyngeal candidosis in a predominantly HIV antibody-positive group of patients, J. Met. Vet. Mycol., 26: 67 (1988).CrossRefGoogle Scholar
  24. 24.
    R.R.Redfield, D.C.Wright, F.C.Tramont, Walter Reed staging classification for HTLV-III/LAV infection, New Engl. J. Med., 314: 131 (1986).Google Scholar
  25. 25.
    R.Matthews, J.Burnie, D.Smith, J.Midgley, et al., Candida and AIDS. Evidence for protective antibody, Lancet (July 30 ): 263 (1988).CrossRefGoogle Scholar
  26. 26.
    A.Durandy, A.Fischer, E.Drouhet, C.Griscelli, Mannan antigen of Candida albicans and cellular immune responses in vitro and in vivo, in: “Fungal Antigens”, E. Drouhet, G.T. Cole, L. De Repentigny, J.P. Latgé, B. Dupont, eds., Plenum Press, New York(1988).Google Scholar
  27. 27.
    A.Fischer, J.J.Ballet, C.Griscelli, Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic muco-cutaneous candidiasis, J. Clin. Invest., 62: 1005 (1978).CrossRefGoogle Scholar
  28. 28.
    R.McLeod and J.S.Remington, Fungal endocarditis, in: “Infective Endocarditis”, S.H. Rahimtoola, ed., pp. 211–290, Grune and Stratton, New York (1978).Google Scholar
  29. 29.
    G.Badillet, P.Pietrini, A.Puissant, Pustuloses chez des héroïnomanes, Ann. Dermatol. Vénéréol., 110: 691 (1983).Google Scholar
  30. 30.
    M.Feuillade de Chauvin and R.Touraine, Folliculite a Candida albicans chez trois heroïnomanes, Bull. Soc. Franc. Mycol. Med., 10: 179 (1983).Google Scholar
  31. 31.
    T.Calandra, P.Francioli, M.P.Glauser, F.Baudraz-Rosselet, C.Ruffieux, D.Grigoriu, Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin, Eur. J. Clin. Microbiol., 4: 340 (1985).PubMedCrossRefGoogle Scholar
  32. 32.
    P.J.Collignon and T.C.Sorrell, Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers, Br. Med. J., 287: 861 (1983).CrossRefGoogle Scholar
  33. 33.
    F.C.Odds, A.Palacio-Hernanz, J.Cuadia, J.Sanchez, Disseminated Candida infection syndrome in heroin addicts - dominance of a single Candida albicans biotype, J. Med. Microbiol., 23: 275 (1987).CrossRefGoogle Scholar
  34. 34.
    J.M.Aguado, C.Barros, M.Fernandez-Guerrero, Cutaneous, ocular and osteoarticular candidosis in patients who are not heroin addicts, J. Infect. Dis., 155: 1082 (1987).CrossRefGoogle Scholar
  35. 35.
    M.Feuillade de Chauvin, A.Cosnes, F.Benkhraba, R.Touraine, Folliculite du cuir chevelu et de la barbe à Candida albicans. Localisation septicémique chez un patient non toxicomane, Ann. Dermatol. Vénéréol., 115: 1162 (1988).Google Scholar
  36. 36.
    J.Bisbe, J.M.Mino, J.M.Torres, X.Latorre, C.Alia, M.Amarol, D.Sitivill, J.M.Mallolas, A.Trilla, Diagnostic value of serum antibody and antigen detection in heroin addicts with systemic candidiasis, Rev. Infect. Dis., 11: 310 (1989).PubMedCrossRefGoogle Scholar
  37. 37.
    S.M.Brown, B.Stimmel, R.N.Taub, S.Kochwa, R.E.Rosenfield, Immunologic dysfunction in heroin addicts, Arch. Intern. Med., 134: 1001 (1974).PubMedCrossRefGoogle Scholar
  38. 38.
    A.Durandy, A.Fisher, F.Le Deist, E.Drouhet, C.Griscelli, Mannanspecific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis, 7: 400 (1987).Google Scholar
  39. 39.
    C.Pankhurst and M.Peakman, Reduced CD4 + T cells and severe oral candidiasis in absence of HIV infection, Lancet (March 25 ): 672 (1989)CrossRefGoogle Scholar
  40. 40.
    E.Drouhet, B.Dupont, T.Dikeacou, Antifungal Agents and Immunity; Z. Gl. Bakt. Suppl. 13, 1, in: “Chemotherapy and Immunity”, G. Pulverer and J. Jeliaszewicz, eds., Gustav Fischer Verlag, Stuttgart, New York (1985).Google Scholar
  41. 41.
    C.H.Kirkpatrick, Chronic mucocutaneous candidiasis: antibiotic and immunologic therapy, in: “Antifungal Drugs”, V.S. Georgiev, ed., Ann New York Acad Sci, 544:471 (1988).Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • E. Drouhet
    • 1
  • B. Dupont
    • 1
  1. 1.Unité de MycologieInstitut PasteurParisFrance

Personalised recommendations